Lamotrigine (Lamictal): A complete overview of what you need to know

Описание к видео Lamotrigine (Lamictal): A complete overview of what you need to know

In this video, we discuss the mood-stabilizing medication, lamotrigine (Lamictal). This medication is an anticonvulsant that is used to treat Bipolar depression and maintenance. In this overview of lamotrigine (Lamictal), we will discuss what lamotrigine (Lamictal) is, what lamotrigine is used for, how long it takes for it to work, is lamotrigine addicting, the side effects of lamotrigine, the drug interactions associated with lamotrigine and lastly, my final thoughts on lamotrigine.
Intro 00:00
What is lamotrigine (Lamictal) 00:48
What is lamotrigine (Lamictal) used for 01:33
How long does it take lamotrigine (Lamictal) to work? 02:21
Is lamotrigine (Lamictal) addicting? 03:40
Side effects of lamotrigine (Lamictal) 04:29
Drug interactions with lamotrigine (Lamictal) 08:09
Final thoughts on lamotrigine (Lamictal) 10:29

Resources:
Deprescribing Guide: https://amzn.to/4dZEUMk
Stahl's Prescribing Guide: https://amzn.to/3UXj8QL

🎥 This video was edited by:
Rahul Kanchi   / rahulkanchi24  

🚑 If you are in a mental health crisis, please dial 9-8-8 from the U.S. Or text HOME to 741741 and connect to a crisis counselor.
You can find a list of international crisis lines here: https://blog.opencounseling.com/suici...

References:
Hashimoto Y, Kotake K, Watanabe N, Fujiwara T, Sakamoto S. Lamotrigine in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev. 2021 Sep 15;9(9):CD013575. doi: 10.1002/14651858.CD013575.pub2. PMID: 34523118; PMCID: PMC8440301.

Lamotrigine (Lamictal) (2015). FDA Label. Retrieved from https://www.accessdata.fda.gov/drugsa...

Stahl, S. M., Grady, M. M., & Muntner, N. (2021). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications. Cambridge University Press.

Stahl,S. (2017). Stahl’s Essential Psychopharmacology: Prescriber’s Guide, 6th Ed. Cambridge University Press.

Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018 Mar;20(2):97-170. doi: 10.1111/bdi.12609. Epub 2018 Mar 14. PMID: 29536616; PMCID: PMC5947163.

Disclaimer: All of the information on this channel is for educational purposes only and not intended to be specific/personal medical advice or substitute for diagnosis and treatment of any conditions discussed herein. Furthermore, watching these videos or getting answers to comments/questions, does not establish a provider-patient relationship. Please consult with your own health care provider for proper diagnosis and treatment.

Комментарии

Информация по комментариям в разработке